Biome Australia Ltd (AU:BIO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biome Australia Ltd has announced that they anticipate a record-breaking first quarter in FY25, with sales revenue expected to exceed $4.0 million. This follows the previous quarter’s high of $3.8 million, signaling ongoing growth for the company that specializes in probiotics and complementary medicines aimed at improving health outcomes. Biome’s products, which are backed by clinical research, cater to various health concerns and are distributed both locally and internationally.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.